Literature DB >> 25803750

Association between medication and intestinal intussusception in children: a case-crossover study.

Lourdes Vega García1, Virginia Fuentes-Leonarte, José María Tenías, Patricia Correcher Medina, Ángel Arias Arias, Carmen Román Ortiz.   

Abstract

OBJECTIVES: This study aimed to assess the association between the appearance of intussusception in children and medication intake in the immediately preceding period (2-15 days).
METHODS: A case-crossover design was used. We selected cases of children admitted with a diagnosis of intussusception (International Classification of Diseases, Ninth Revision, 860) to the major hospitals in the city of Valencia, Spain, from 2006 to 2009. We then estimated the association between the episode of intussusception and the intake of prescription medication during the preceding 2, 7, and 15 days (case period) and for the same time window 1, 2, 3, and 4 months prior (control period). Data on previous drug administration were obtained from the Pharmaceutical Service Manager System.
RESULTS: A total of 95 cases (65.3% boys and 34.7% girls) were selected; 76.6% were younger than the age of 2 years. The association between intussusception and prior drug use varied depending on the exposure window: 15-day odds ratio (OR), 1.45 (95% confidence interval [95% CI], 0.86-2.43); 7-day OR, 1.46 (95% CI, 0.80-2.67); and 2-day OR, 2.26 (95% CI, 1.10-4.64). These associations were greater for children aged younger than 2 years and were usually due to the recent administration (preceding 2 days) of antibiotics (OR, 8.00; 95% CI, 1.47-43.7).
CONCLUSIONS: Intussusception was more common among boys aged younger than 2 years. A positive and significant association was observed when drugs were administered 2 to 7 days before the onset of symptoms in children younger than the age of 2 years.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25803750     DOI: 10.1097/PEC.0000000000000397

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  1 in total

1.  Reply letter and clarifications on behalf of La Rosa and colleagues to Sicilian Public Health Authorities.

Authors:  Francesco La Rosa; Grasso Chiara; Valeria La Rosa; Valentina Taranto; Concetta Maria Spinello; Giuseppa La Camera; Marinella Astuto
Journal:  Hum Vaccin Immunother       Date:  2016-08-23       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.